Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Elena Vega

FORGOTTEN HISTORY: Wegovy pill passed 100 000 prescriptions in two months a faster start than injectable wegovy or zepbound had - The Untold Story

The Wegovy pill topped 100,000 prescriptions within its first two months on the U.S. market, a steeper early climb than injectable Wegovy or Zepbound showed at their launches, according to a study in the Annals of Internal Medicine reported by Healio. Researchers analyzed national prescription data from July 2020 through June 2026.

Prescriptions for injectable semaglutide and injectable tirzepatide kept rising after the pill arrived. The researchers concluded the pill mainly added new users rather than pulling patients away from shots.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.